Related Experiment Video
Updated: Jul 9, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
GPR26: a marker for primary glioblastoma?
Alan N Carter1, Clare L Cole, Adam G Playle
1Brain Tumour North West, Faculty of Science, University of Central Lancashire, Preston, UK. aashervington@uclan.ac.uk
Molecular and Cellular Probes
|November 27, 2007
Summary
This study found GPR26 is less transcribed in older glioblastoma patients, suggesting it may suppress tumor development. GPR26 acts as a potential genetic marker for primary glioblastoma.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- Glioblastomas are aggressive brain tumors with poor prognosis.
- Classified as primary (de novo) or secondary (from pre-existing glioma).
- Need for novel genetic markers in glioblastoma diagnosis and prognosis.
Purpose of the Study:
- Investigate differential GPR26 gene transcription in glioblastoma tissues.
- Determine if GPR26 serves as a candidate genetic marker.
- Correlate GPR26 transcription with patient age and glioblastoma type.
Main Methods:
- Polymerase Chain Reaction (PCR) used to analyze GPR26 transcription.
- Compared GPR26 expression in seven glioblastoma tissues and two normal brain tissues.
- Analyzed transcription ratios between normal and cancerous samples, and across age groups (<50 and >60 years).
Main Results:
- GPR26 was transcribed in glioblastoma tissues but not in tested cell lines.
- Significantly lower GPR26 transcription observed in tissues from older patients (p=0.03).
- Differential transcription suggests GPR26's role in glioblastoma development.
Conclusions:
- GPR26 identified as a potential genetic indicator for primary glioblastoma.
- GPR26 may function as a suppressor of primary glioblastoma development.
- Further research warranted to elucidate GPR26's role in neuro-oncology.
